These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29265731)

  • 41. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.
    Hibbs BF; Moro PL; Lewis P; Miller ER; Shimabukuro TT
    Vaccine; 2015 Jun; 33(28):3171-8. PubMed ID: 25980429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SSEL-ADE: A semi-supervised ensemble learning framework for extracting adverse drug events from social media.
    Liu J; Zhao S; Wang G
    Artif Intell Med; 2018 Jan; 84():34-49. PubMed ID: 29111222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records.
    Banda JM; Callahan A; Winnenburg R; Strasberg HR; Cami A; Reis BY; Vilar S; Hripcsak G; Dumontier M; Shah NH
    Drug Saf; 2016 Jan; 39(1):45-57. PubMed ID: 26446143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
    Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
    Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
    Aagaard L; Hallgreen CE; Hansen EH
    Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methods for safety signal detection in healthcare databases: a literature review.
    Arnaud M; Bégaud B; Thurin N; Moore N; Pariente A; Salvo F
    Expert Opin Drug Saf; 2017 Jun; 16(6):721-732. PubMed ID: 28490262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China.
    Hou Y; Ye X; Wu G; Cheng G; Du X; He J
    Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barriers to the reporting of medication administration errors and near misses: an interview study of nurses at a psychiatric hospital.
    Haw C; Stubbs J; Dickens GL
    J Psychiatr Ment Health Nurs; 2014; 21(9):797-805. PubMed ID: 24646372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fifty years of pharmacovigilance - Medicines safety and public health.
    Laporte JR
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
    [No Abstract]   [Full Text] [Related]  

  • 50. Pediatric post-marketing safety systems in North America: assessment of the current status.
    McMahon AW; Wharton GT; Bonnel R; DeCelle M; Swank K; Testoni D; Cope JU; Smith PB; Wu E; Murphy MD
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):785-92. PubMed ID: 26098297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient safety incident reports related to traditional Japanese Kampo medicines: medication errors and adverse drug events in a university hospital for a ten-year period.
    Shimada Y; Fujimoto M; Nogami T; Watari H; Kitahara H; Misawa H; Kimbara Y
    BMC Complement Altern Med; 2017 Dec; 17(1):547. PubMed ID: 29268743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
    Krähenbühl S
    Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Safety of Drug Therapy in Children.
    Wimmer S; Neubert A; Rascher W
    Dtsch Arztebl Int; 2015 Nov; 112(46):781-7. PubMed ID: 26806565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
    Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
    Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The benefits of data mining.
    Bone A; Houck K
    Elife; 2017 Aug; 6():. PubMed ID: 28813246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.
    Pratt N; Chan EW; Choi NK; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Ooba N; Park BJ; Sato T; Shin JY; Wong IC; Kao Yang YH; Roughead EE
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):858-64. PubMed ID: 25907076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse drug reactions to self-medication: a study in a pharmacovigilance database.
    Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL
    Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adverse Event Trends Associated with Over-the-counter Drugs: Data Mining of the Japanese Adverse Drug Event Report Database].
    Umetsu R; Abe J; Ueda N; Kato Y; Nakayama Y; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2015; 135(8):991-1000. PubMed ID: 26234358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention.
    Goedecke T; Ord K; Newbould V; Brosch S; Arlett P
    Drug Saf; 2016 Jun; 39(6):491-500. PubMed ID: 26940903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014.
    Awodele O; Ibrahim A; Orhii P
    Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.